JP2023550840A5 - - Google Patents
Info
- Publication number
- JP2023550840A5 JP2023550840A5 JP2023532331A JP2023532331A JP2023550840A5 JP 2023550840 A5 JP2023550840 A5 JP 2023550840A5 JP 2023532331 A JP2023532331 A JP 2023532331A JP 2023532331 A JP2023532331 A JP 2023532331A JP 2023550840 A5 JP2023550840 A5 JP 2023550840A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20210189.5 | 2020-11-27 | ||
| EP20210189 | 2020-11-27 | ||
| PCT/EP2021/083141 WO2022112490A1 (en) | 2020-11-27 | 2021-11-26 | Amino quinazoline derivatives as p2x3 inhibitors |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023550840A JP2023550840A (ja) | 2023-12-05 |
| JP2023550840A5 true JP2023550840A5 (https=) | 2024-11-29 |
| JPWO2022112490A5 JPWO2022112490A5 (https=) | 2024-11-29 |
| JP7844468B2 JP7844468B2 (ja) | 2026-04-13 |
Family
ID=73642588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023532331A Active JP7844468B2 (ja) | 2020-11-27 | 2021-11-26 | Ｐ２ｘ３阻害剤としてのアミノキナゾリン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240025880A1 (https=) |
| EP (1) | EP4251620B1 (https=) |
| JP (1) | JP7844468B2 (https=) |
| KR (1) | KR20230113309A (https=) |
| CN (1) | CN116601149A (https=) |
| AU (1) | AU2021388923A1 (https=) |
| CA (1) | CA3196333A1 (https=) |
| ES (1) | ES3026309T3 (https=) |
| MX (1) | MX2023005803A (https=) |
| WO (1) | WO2022112490A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121368584A (zh) | 2023-05-22 | 2026-01-20 | 奇斯药制品公司 | 用于制备p2x3抑制剂的方法及中间体 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2592070B1 (en) | 2006-06-29 | 2016-08-31 | F. Hoffmann-La Roche AG | Tetrazole-substituted arylamides |
| CA2682162C (en) | 2007-04-02 | 2016-05-10 | Renovis, Inc. | Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof |
| JP5498374B2 (ja) | 2007-04-17 | 2014-05-21 | エボテック・アーゲー | ２−シアノフェニル縮合複素環式化合物および組成物、ならびにその使用 |
| MX2010009561A (es) | 2008-02-29 | 2010-09-24 | Renovis Inc | Compuestos amida, composiciones y usos de los mismos. |
| CA2737038A1 (en) | 2008-09-18 | 2010-03-25 | Evotec Ag | Amide compounds, compositions and uses thereof |
| WO2016084922A1 (ja) | 2014-11-28 | 2016-06-02 | 塩野義製薬株式会社 | １，２，４－トリアジン誘導体およびその医薬組成物 |
| WO2016088838A1 (ja) | 2014-12-04 | 2016-06-09 | 塩野義製薬株式会社 | プリン誘導体およびその医薬組成物 |
| HUE058009T2 (hu) | 2014-12-09 | 2022-06-28 | Bayer Ag | 1,3-Tiazol-2-il szubsztituált benzamid-származékok |
| WO2017011729A1 (en) | 2015-07-16 | 2017-01-19 | Patara Pharma, LLC | Combination therapies for the treatment of lung diseases |
| KR20180054843A (ko) | 2015-09-29 | 2018-05-24 | 애퍼런트 파마슈티컬스 인크. | 기침 치료에 사용하기 위한 디아미노피리미딘 p2x3 및 p2x2/3 수용체 조정제 |
| BR112021022099A2 (pt) * | 2019-05-31 | 2021-12-28 | Chiesi Farm Spa | Derivados de amino quinazolina como inibidores de p2x3 |
-
2021
- 2021-11-26 AU AU2021388923A patent/AU2021388923A1/en active Pending
- 2021-11-26 WO PCT/EP2021/083141 patent/WO2022112490A1/en not_active Ceased
- 2021-11-26 CA CA3196333A patent/CA3196333A1/en active Pending
- 2021-11-26 CN CN202180079588.2A patent/CN116601149A/zh active Pending
- 2021-11-26 KR KR1020237018300A patent/KR20230113309A/ko active Pending
- 2021-11-26 US US18/038,744 patent/US20240025880A1/en active Pending
- 2021-11-26 MX MX2023005803A patent/MX2023005803A/es unknown
- 2021-11-26 EP EP21811098.9A patent/EP4251620B1/en active Active
- 2021-11-26 ES ES21811098T patent/ES3026309T3/es active Active
- 2021-11-26 JP JP2023532331A patent/JP7844468B2/ja active Active